Investor Relations

We are a global, high-growth diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology. Our proprietary T-SPOT® technology platform allows us to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human body’s immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases.

This section of our website offers a significant amount of information for the investor community. If you have questions or comments after reviewing the information provided here, our Investor Relations department may be reached through the "Contact Us" tab.

NASDAQ: OXFD
14.49
- 0.35 (-2.36%)
Day High: 14.79
Day Low:  14.40
Volume:    62,127
2:53 PM ET on Dec 7, 2016

Delayed at least 20 minutes.